James Armitage

James Armitage

Director/Board Member at TESARO INC

Net worth: 52 231 $ as of 31/05/2026

79 year
Health Technology
Consumer Services
Health Services

Profile

Dr. James O.
Armitage
, MD, is an Independent Director at Cardiff Oncology, Inc. and a Professor-Internal Medicine at University of Nebraska Medical Center.
He is on the Board of Directors at Cardiff Oncology, Inc. and Tesaro, Inc. Dr. Armitage was previously employed as a President by American Society for Blood & Marrow Transplantation and a President & Director by American Society of Clinical Oncology, Inc. He also served on the board at MGI PHARMA, Inc. He received his undergraduate degree from the University of Nebraska and a doctorate degree from the University of Nebraska Medical Center.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
11/06/2026 27,490 ( 0.04% ) 52 231 $ 31/05/2026

James Armitage active positions

CompaniesPositionStart
TESARO INC Director/Board Member 09/05/2013
CARDIFF ONCOLOGY, INC. Director/Board Member 22/04/2020
Corporate Officer/Principal 01/01/1982

Former positions of James Armitage

CompaniesPositionEnd
Director/Board Member 29/01/2008
President -
President -
See the detail of James Armitage's experience

Training of James Armitage

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

58

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Services

  1. Stock Market
  2. Insiders
  3. James Armitage